Surgery Flashcards
Abdominal aortic aneurysm
Abdominal aortic aneurysms occur primarily as a result of the failure of elastic proteins within the extracellular matrix. Aneurysms typically represent dilation of all layers of the arterial wall. Most aneurysms are caused by degenerative disease. After the age of 50 years the normal diameter of the infrarenal aorta is 1.5cm in females and 1.7cm in males. Diameters of 3cm and greater, are considered aneurysmal. The pathophysiology involved in the development of aneurysms is complex and the primary event is loss of the intima with loss of elastic fibres from the media. This process is associated with, and potentiated by, increased proteolytic activity and lymphocytic infiltration.
Major risk factors for the development of aneurysms include smoking and hypertension. Rare but important causes include syphilis and connective tissues diseases such as Ehlers Danlos type 1 and Marfans syndrome.
Abdominal pain
The table below gives characteristic exam question features for conditions causing abdominal pain. Unusual and ‘medical’ causes of abdominal pain should also be remembered:
myocardial infarction
diabetic ketoacidosis
pneumonia
acute intermittent porphyria
lead poisoning
Condition
Characteristic exam feature
Peptic ulcer disease
Duodenal ulcers: more common than gastric ulcers, epigastric pain relieved by eating
Gastric ulcers: epigastric pain worsened by eating
Features of upper gastrointestinal haemorrhage may be seen (haematemesis, melena etc)
Appendicitis
Pain initial in the central abdomen before localising to the right iliac fossa
Anorexia is common
Tachycardia, low-grade pyrexia, tenderness in RIF
Rovsing’s sign: more pain in RIF than LIF when palpating LIF
Acute pancreatitis
Usually due to alcohol or gallstones
Severe epigastric pain
Vomiting is common
Examination may reveal tenderness, ileus and low-grade fever
Periumbilical discolouration (Cullen’s sign) and flank discolouration (Grey-Turner’s sign) is described but rare
Biliary colic
Pain in the RUQ radiating to the back and interscapular region, may be following a fatty meal. Slight misnomer as the pain may persist for hours
Obstructive jaundice may cause pale stools and dark urine
It is sometimes taught that patients are female, forties, fat and fair although this is obviously a generalisation
Acute cholecystitis
History of gallstones symptoms (see above)
Continuous RUQ pain
Fever, raised inflammatory markers and white cells
Murphy’s sign positive (arrest of inspiration on palpation of the RUQ)
Diverticulitis
Colicky pain typically in the LLQ
Fever, raised inflammatory markers and white cells
Abdominal aortic aneurysm
Severe central abdominal pain radiating to the back
Presentation may be catastrophic (e.g. Sudden collapse) or sub-acute (persistent severe central abdominal pain with developing shock)
Patients may have a history of cardiovascular disease
Intestinal obstruction
History of malignancy/previous operations
Vomiting
Not opened bowels recently
‘Tinkling’ bowel sounds
Abdominal swelling
The table below gives characteristic exam question features for conditions causing abdominal swelling
Condition
Characteristic exam feature
Pregnancy
Young female
Amenorrhoea
Intestinal obstruction
History of malignancy/previous operations
Vomiting
Not opened bowels recently
‘Tinkling’ bowel sounds
Ascites
History of alcohol excess, cardiac failure
Urinary retention
History of prostate problems
Dullness to percussion around suprapubic area
Ovarian cancer
Older female
Pelvic pain
Urinary symptoms e.g. urgency
Raised CA125
Early satiety, bloating
Abdominal wall hernias
The classical surgical definition of a hernia is the protrusion of an organ or the fascia of an organ through the wall of the cavity that normally contains it.
Risk factors for abdominal wall hernias include:
obesity
ascites
increasing age
surgical wounds
Features
palpable lump
cough impulse
pain
obstruction: more common in femoral hernias
strangulation: may compromise the bowel blood supply leading to infarction
Types of abdominal wall hernias:
Type of hernia
Details
Inguinal hernia
Inguinal hernias account for 75% of abdominal wall hernias. Around 95% of patients are male; men have around a 25% lifetime risk of developing an inguinal hernia.
Above and medial to pubic tubercle
Strangulation is rare
Femoral hernia
Below and lateral to the pubic tubercle
More common in women, particularly multiparous ones
High risk of obstruction and strangulation
Surgical repair is required
Umbilical hernia
Symmetrical bulge under the umbilicus
Paraumbilical hernia
Asymmetrical bulge - half the sac is covered by skin of the abdomen directly above or below the umbilicus
Epigastric hernia
Lump in the midline between umbilicus and the xiphisternum
Most common in men aged 20-30 years
Incisional hernia
May occur in up to 10% of abdominal operations
Spigelian hernia
Also known as lateral ventral hernia
Rare and seen in older patients
A hernia through the spigelian fascia (the aponeurotic layer between the rectus abdominis muscle medially and the semilunar line laterally)
Obturator hernia
A hernia which passes through the obturator foramen. More common in females and typical presents with bowel obstruction
Richter hernia
A rare type of hernia where only the antimesenteric border of the bowel herniates through the fascial defect
Richter’s hernia can present with strangulation without symptoms of obstruction
Abdominal wall hernias in children:
Type of hernia
Details
Congenital inguinal hernia
Indirect hernias resulting from a patent processus vaginalis
Occur in around 1% of term babies. More common in premature babies and boys
60% are right sided, 10% are bilaterally
Should be surgically repaired soon after diagnosis as at risk of incarceration
Infantile umbilical hernia
Symmetrical bulge under the umbilicus
More common in premature and Afro-Caribbean babies
The vast majority resolve without intervention before the age of 4-5 years
Complications are rare
Acute pancreatitis: causes
The vast majority of acute pancreatitis in the UK are caused by gallstones and alcohol
Popular mnemonic is GET SMASHED
Gallstones
Ethanol
Trauma
Steroids
Mumps (other viruses include Coxsackie B)
Autoimmune (e.g. polyarteritis nodosa), Ascaris infection
Scorpion venom
Hypertriglyceridaemia, Hyperchylomicronaemia, Hypercalcaemia, Hypothermia
ERCP
Drugs (azathioprine, mesalazine*, didanosine, bendroflumethiazide, furosemide, pentamidine, steroids, sodium valproate)
Anal fissure
Anal fissures are longitudinal or elliptical tears of the squamous lining of the distal anal canal. If present for less than 6 weeks they are defined as acute, and chronic if present for more than 6 weeks.
Risk factors
constipation
inflammatory bowel disease
sexually transmitted infections e.g. HIV, syphilis, herpes
Features
painful, bright red, rectal bleeding
around 90% of anal fissures occur on the posterior midline.
if the fissures are found in alternative locations then other underlying causes should be considered e.g. Crohn’s disease
Management of an acute anal fissure (< 6 weeks)
dietary advice: high-fibre diet with high fluid intake
bulk-forming laxatives are first-line - if not tolerated then lactulose should be tried
lubricants such as petroleum jelly may be tried before defecation
topical anaesthetics
analgesia
topical steroids do not provide significant relief
Management of a chronic anal fissure (> 6 weeks)
the above techniques should be continued
topical glyceryl trinitrate (GTN) is first-line treatment for a chronic anal fissure
if topical GTN is not effective after 8 weeks then secondary care referral should be considered for surgery (sphincterotomy) or botulinum toxin
The combination of pain and bleeding is very characteristic of anal fissures. Pain is a feature of thrombosed external haemorrhoids but is unusual with internal haemorrhoids. Superficial anal fissures may be difficult to see on examination.
Anal fissure
Anal fissures are longitudinal or elliptical tears of the squamous lining of the distal anal canal. If present for less than 6 weeks they are defined as acute, and chronic if present for more than 6 weeks.
Risk factors
constipation
inflammatory bowel disease
sexually transmitted infections e.g. HIV, syphilis, herpes
Features
painful, bright red, rectal bleeding
around 90% of anal fissures occur on the posterior midline.
if the fissures are found in alternative locations then other underlying causes should be considered e.g. Crohn’s disease
Management of an acute anal fissure (< 6 weeks)
dietary advice: high-fibre diet with high fluid intake
bulk-forming laxatives are first-line - if not tolerated then lactulose should be tried
lubricants such as petroleum jelly may be tried before defecation
topical anaesthetics
analgesia
topical steroids do not provide significant relief
Management of a chronic anal fissure (> 6 weeks)
the above techniques should be continued
topical glyceryl trinitrate (GTN) is first-line treatment for a chronic anal fissure
if topical GTN is not effective after 8 weeks then secondary care referral should be considered for surgery (sphincterotomy) or botulinum toxin
Anti-oestrogen drugs
Selective oEstrogen Receptor Modulators (SERM)
Tamoxifen is a SERM which acts as an oestrogen receptor antagonist and partial agonist. It is used in the management of oestrogen receptor-positive breast cancer.
Adverse effects
menstrual disturbance: vaginal bleeding, amenorrhoea
hot flushes - 3% of patients stop taking tamoxifen due to climateric side-effects
venous thromboembolism
endometrial cancer
osteoporosis
Aromatase inhibitors
Anastrozole and letrozole are aromatase inhibitors that reduces peripheral oestrogen synthesis. This is important as aromatisation accounts for the majority of oestrogen production in postmenopausal women and therefore anastrozole is used for ER +ve breast cancer in this group.
Adverse effects
osteoporosis
hot flushes
arthralgia, myalgia
insomnia
Ascending cholangitis
Ascending cholangitis is a bacterial infection (typically E. coli) of the biliary tree. The most common predisposing factor is gallstones.
Charcot’s triad of right upper quadrant (RUQ) pain, fever and jaundice occurs in about 20-50% of patients
fever is the most common feature, seen in 90% of patients
RUQ pain 70%
jaundice 60%
hypotension and confusion are also common (the additional 2 factors in addition to the 3 above make Reynolds’ pentad)
Other features
raised inflammatory markers
Management
intravenous antibiotics
endoscopic retrograde cholangiopancreatography (ERCP) after 24-48 hours to relieve any obstruction
Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a common condition seen in older men.
Risk factors
age: around 50% of 50-year-old men will have evidence of BPH and 30% will have symptoms. Around 80% of 80-year-old men have evidence of BPH
ethnicity: black > white > Asian
BPH typically presents with lower urinary tract symptoms (LUTS), which may be categorised into:
voiding symptoms (obstructive): weak or intermittent urinary flow, straining, hesitancy, terminal dribbling and incomplete emptying
storage symptoms (irritative) urgency, frequency, urgency incontinence and nocturia
post-micturition: dribbling
complications: urinary tract infection, retention, obstructive uropathy
Management options
watchful waiting
medication: alpha-1 antagonists, 5 alpha-reductase inhibitors. The use of combination therapy was supported by the Medical Therapy Of Prostatic Symptoms (MTOPS) trial
surgery: transurethral resection of prostate (TURP)
Alpha-1 antagonists e.g. tamsulosin, alfuzosin
decrease smooth muscle tone (prostate and bladder)
considered first-line, improve symptoms in around 70% of men
adverse effects: dizziness, postural hypotension, dry mouth, depression
5 alpha-reductase inhibitors e.g. finasteride
block the conversion of testosterone to dihydrotestosterone (DHT), which is known to induce BPH
unlike alpha-1 antagonists causes a reduction in prostate volume and hence may slow disease progression. This however takes time and symptoms may not improve for 6 months. They may also decrease PSA concentrations by up to 50%
adverse effects: erectile dysfunction, reduced libido, ejaculation problems, gynaecomastia
Blood Products
This patient is actively bleeding. The consultant appreciates the need to replace this individual with blood products. Over resuscitation using 0.9% saline can result in dilutional anaemia. This does not improve oxygen transport/ delivery or coagulopathy.
In patients for whom we do not know their blood group, O rhesus negative blood may be prescribed. O rhesus negative is considered the universal donor. O rhesus negative can give blood to any other blood group.
It is imperative to prescribe 1. The correct blood product. 2. The right product for the right patient. Transfusion reactions are serious and deadly.
Excellent resource for blood groups - https://www.pathology.med.umich.edu/bloodbank/manual/bbchart/
Blood products - cross matching
Whole blood fractions
Fraction
Key points
Packed red cells
Used for transfusion in chronic anaemia and cases where infusion of large volumes of fluid may result in cardiovascular compromise. Product obtained by centrifugation of whole blood.
Platelet rich plasma
Usually administered to patients who are thrombocytopaenic and are bleeding or require surgery. It is obtained by low speed centrifugation.
Platelet concentrate
Prepared by high speed centrifugation and administered to patients with thrombocytopaenia.
Fresh frozen plasma
Prepared from single units of blood.
Contains clotting factors, albumin and immunoglobulin.
Unit is usually 200 to 250ml.
Usually used in correcting clotting deficiencies in patients with hepatic synthetic failure who are due to undergo surgery.
Usual dose is 12-15ml/Kg-1.
It should not be used as first line therapy for hypovolaemia.
Cryoprecipitate
Formed from supernatant of FFP.
Rich source of Factor VIII and fibrinogen.
Allows large concentration of factor VIII to be administered in small volume.
SAG-Mannitol Blood
Removal of all plasma from a blood unit and substitution with:
Sodium chloride
Adenine
Anhydrous glucose
Mannitol
Up to 4 units of SAG M Blood may be administered. Thereafter whole blood is preferred. After 8 units, clotting factors and platelets should be considered.
Cross matching
Must be cross matched
Can be ABO incompatible in adults
Packed red cells
Platelets
Fresh frozen plasma
Cryoprecipitate
Whole blood
Brain death
Criteria for brain stem death testing
Deep coma of known aetiology.
Reversible causes excluded
No sedation
Normal electrolytes
Testing for brain death
Fixed pupils which do not respond to sharp changes in the intensity of incident light
No corneal reflex
Absent oculo-vestibular reflexes - no eye movements following the slow injection of at least 50ml of ice-cold water into each ear in turn (the caloric test)
No response to supraorbital pressure
No cough reflex to bronchial stimulation or gagging response to pharyngeal stimulation
No observed respiratory effort in response to disconnection of the ventilator for long enough (typically 5 minutes) to ensure elevation of the arterial partial pressure of carbon dioxide to at least 6.0 kPa (6.5 kPa in patients with chronic carbon dioxide retention). Adequate oxygenation is ensured by pre-oxygenation and diffusion oxygenation during the disconnection (so the brain stem respiratory centre is not challenged by the ultimate, anoxic, drive stimulus)
The test should be undertaken by two appropriately experienced doctors on two separate occasions. Both should be experienced in performing brain stem death testing and have at least 5 years post graduate experience. One of them must be a consultant. Neither can be a member of the transplant team (if organ donation contemplated).
Breast cancer screening
The NHS Breast Screening Programme is being expanded to include women aged 47-73 years from the previous parameter of 50-70 years. Women are offered a mammogram every 3 years. After the age of 70 years women may still have mammograms but are ‘encouraged to make their own appointments’.
The effectiveness of breast screening is regularly debated although it is currently thought that the NHS Breast Screening Programme may save around 1,400 lives per year.
Familial breast cancer
NICE published guidelines on the management of familial breast cancer in 2013, giving guidelines on who needs referral.
If the person concerned only has one first-degree or second-degree relative diagnosed with breast cancer they do NOT need to be referred unless any of the following are present in the family history:
age of diagnosis < 40 years
bilateral breast cancer
male breast cancer
ovarian cancer
Jewish ancestry
sarcoma in a relative younger than age 45 years
glioma or childhood adrenal cortical carcinomas
complicated patterns of multiple cancers at a young age
paternal history of breast cancer (two or more relatives on the father’s side of the family)
Women who are at an increased risk of breast cancer due to their family history may be offered screening from a younger age. The following patients should be referred to the breast clinic for further assessment:
one first-degree female relative diagnosed with breast cancer at younger than age 40 years, or
one first-degree male relative diagnosed with breast cancer at any age, or
one first-degree relative with bilateral breast cancer where the first primary was diagnosed at younger than age 50 years, or
two first-degree relatives, or one first-degree and one second-degree relative, diagnosed with breast cancer at any age, or
one first-degree or second-degree relative diagnosed with breast cancer at any age and one first-degree or second-degree relative diagnosed with ovarian cancer at any age (one of these should be a first-degree relative), or
three first-degree or second-degree relatives diagnosed with breast cancer at any age
NICE guidelines suggest a cut-off age of 30 years when a woman has an unexplained breast lump with or without pain. As this 28-year-old is below this cut-off she should be referred non-urgently to the local breast services.
Breast cancer: referral
NICE published referral guidelines for suspected breast cancer in 2015 (our emphasis):
Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for breast cancer if they are:
aged 30 and over and have an unexplained breast lump with or without pain or
aged 50 and over with any of the following symptoms in one nipple only: discharge, retraction or other changes of concern
Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for breast cancer in people:
with skin changes that suggest breast cancer or
aged 30 and over with an unexplained lump in the axilla
Consider non-urgent referral in people aged under 30 with an unexplained breast lump with or without pain.
Paternal family history of breast cancer - secondary care referral
Importance: 43
Paternal family history of breast cancer warrants a secondary care referral.
Breast cancer might not be evident in breast examination hence option 1 and 5 are incorrect.
Waiting for the routine screen may delay the diagnosis as she is at high risk for familial breast cancer.
Review in one year may delay the diagnosis.
Basic breast anatomy
Most breast cancers arise from duct tissue followed by lobular tissue, described as ductal or lobular carcinoma respectively. These can be further subdivided as to whether the cancer hasn’t spread beyond the local tissue (described as carcinoma-in-situ) or has spread (described as invasive). Therefore, common breast cancer types include:
Invasive ductal carcinoma. This is the most common type of breast cancer. To complicate matters further this has recently been renamed ‘No Special Type (NST)’. In contrast, lobular carcinoma and other rarer types of breast cancer are classified as ‘Special Type’
Invasive lobular carcinoma
Ductal carcinoma-in-situ (DCIS)
Lobular carcinoma-in-situ (LCIS)
Rarer types of breast cancer are shown in the following list. These are classed as ‘Special Type’ but as noted previously remember that a relatively common type of breast cancer (lobular) is also Special Type:
Medullary breast cancer
Mucinous (mucoid or colloid) breast cancer
Tubular breast cancer
Adenoid cystic carcinoma of the breast
Metaplastic breast cancer
Lymphoma of the breast
Basal type breast cancer
Phyllodes or cystosarcoma phyllodes
Papillary breast cancer
Other types of breast cancer include the following (although please note they may be associated with the underlying lesions seen above, rather than completely separate subtypes):
Paget’s disease of the nipple is an eczematoid change of the nipple associated with an underlying breast malignancy and it is present in 1-2% of patients with breast cancer. In half of these patients, it is associated with an underlying mass lesion and 90% of such patients will have an invasive carcinoma. 30% of patients without a mass lesion will still be found to have an underlying carcinoma. The remainder will have carcinoma in situ.
Inflammatory breast cancer where cancerous cells block the lymph drainage resulting in an inflamed appearance of the breast. This accounts for around 1 in 10,000 cases of breast cancer.
Tamoxifen is used as the women is pre-menopausal. There is ongoing debate about whether therapy should be for 5 years or longer.
management of breast cancer
Breast cancer: management
The management of breast cancer depends on the staging, tumour type and patient background. It may involve any of the following:
surgery
radiotherapy
hormone therapy
biological therapy
chemotherapy
Surgery
The vast majority of patients who have breast cancer diagnosed will be offered surgery. An exception may be a very frail, elderly lady with metastatic disease who may be better managed with hormonal therapy.
Prior to surgery, the presence/absence of axillary lymphadenopathy determines management:
women with no palpable axillary lymphadenopathy at presentation should have a pre-operative axillary ultrasound before their primary surgery
if positive then they should have a sentinel node biopsy to assess the nodal burden
in patients with breast cancer who present with clinically palpable lymphadenopathy, axillary node clearance is indicated at primary surgery
this may lead to arm lymphedema and functional arm impairment
Depending on the characteristics of the tumour women either have a wide-local excision or a mastectomy. Around two-thirds of tumours can be removed with a wide-local excision. The table below lists some of the factors determining which operation is offered:
Mastectomy
Women should be offered breast reconstruction to achieve a cosmetically suitable result regardless of the type of operation they have. For women who’ve had a mastectomy this may be done at the initial operation or at a later date.
Radiotherapy
Whole breast radiotherapy is recommended after a woman has had a wide-local excision as this may reduce the risk of recurrence by around two-thirds. For women who’ve had a mastectomy radiotherapy is offered for T3-T4 tumours and for those with four or more positive axillary nodes
Hormonal therapy
Adjuvant hormonal therapy is offered if tumours are positive for hormone receptors. For many years this was done using tamoxifen for 5 years after diagnosis. Tamoxifen is still used in pre- and peri-menopausal women. In post-menopausal women, aromatase inhibitors such as anastrozole are used for this purpose*. This is important as aromatisation accounts for the majority of oestrogen production in post-menopausal women and therefore anastrozole is used for ER +ve breast cancer in this group.
Important side-effects of tamoxifen include an increased risk of endometrial cancer, venous thromboembolism and menopausal symptoms.
Biological therapy
The most common type of biological therapy used for breast cancer is trastuzumab (Herceptin). It is only useful in the 20-25% of tumours that are HER2 positive.
Trastuzumab cannot be used in patients with a history of heart disorders.
Chemotherapy
Cytotoxic therapy may be used either prior to surgery (‘neoadjuvanant’ chemotherapy) to downstage a primary lesion or after surgery depending on the stage of the tumour, for example, if there is axillary node disease - FEC-D is used in this situation.
HRT, early menarche, late menopause and COCP all increase the risk of breast cancer whereas multiple pregnancy and breastfeeding reduce the risk
Important for meLess important
The correct answer here is early menarche which is a risk factor for breast cancer along with late menopause, combined oral contraceptive use and hormone replacement therapy.
Multiple pregnancy and breastfeeding are protective and reduce the risk of breast cancer.
Breast disorders
The table below describes some of the features seen in the most common breast disorders:
Disorder
Features
Fibroadenoma
Common in women under the age of 30 years
Often described as ‘breast mice’ due as they are discrete, non-tender, highly mobile lumps
Fibroadenosis (fibrocystic disease, benign mammary dysplasia)
Most common in middle-aged women
‘Lumpy’ breasts which may be painful. Symptoms may worsen prior to menstruation
Breast cancer
Characteristically a hard, irregular lump. There may be associated nipple inversion or skin tethering
Paget’s disease of the breast - intraductal carcinoma associated with a reddening and thickening (may resemble eczematous changes) of the nipple/areola
Mammary duct ectasia
Dilatation of the large breast ducts
Most common around the menopause
May present with a tender lump around the areola +/- a green nipple discharge
If ruptures may cause local inflammation, sometimes referred to as ‘plasma cell mastitis’
Duct papilloma
Local areas of epithelial proliferation in large mammary ducts
Hyperplastic lesions rather than malignant or premalignant
May present with blood stained discharge
Fat necrosis
More common in obese women with large breasts
May follow trivial or unnoticed trauma
Initial inflammatory response, the lesion is typical firm and round but may develop into a hard, irregular breast lump
Rare and may mimic breast cancer so further investigation is always warranted
Breast abscess
More common in lactating women
Red, hot tender swelling
Lipomas and sebaceous cysts may also develop around the breast tissue.
Fat necrosis of the breast
Fat necrosis
Up to 40% cases usually have a traumatic aetiology
Physical features usually mimic carcinoma
Mass may increase in size initially
Consider non-urgent referral in people aged < 30 years with an unexplained breast lump with or without pain
Importance: 49
Consider non-urgent referral in people aged < 30 years with an unexplained breast lump with or without pain.
Two-week rule referral is not necessary at this stage.
She needs to be referred. Review by GP in 6 months or one year might delay the diagnosis.
Having no follow-up is not appropriate as this patient needs to have the appropriate investigations.